On the public citation graph
Ivermectin for preventing and treating COVID-19
0 signed · 60 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2020.14103openalex-snapshot
Recovery From Severe COVID-19
inferredcites →https://doi.org/10.1002/9781119536604openalex-snapshot
Cochrane Handbook for Systematic Reviews of Interventions
inferredcites →https://doi.org/10.1016/j.antiviral.2013.06.002openalex-snapshot
Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
inferredcites →https://doi.org/10.1016/j.antiviral.2020.104760openalex-snapshot
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
inferredcites →https://doi.org/10.1016/j.antiviral.2020.104787openalex-snapshot
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
inferredcites →https://doi.org/10.1016/j.ijantimicag.2019.05.003openalex-snapshot
Ivermectin: From theory to clinical application
inferredcites →https://doi.org/10.1016/j.jclinepi.2010.07.015openalex-snapshot
GRADE guidelines: 3. Rating the quality of evidence
inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
inferredcites →https://doi.org/10.1016/s1473-3099(20)30120-1openalex-snapshot
An interactive web-based dashboard to track COVID-19 in real time
inferredcites →https://doi.org/10.1016/s1473-3099(20)30483-7openalex-snapshot
A minimal common outcome measure set for COVID-19 clinical research
inferredcites →https://doi.org/10.1016/s2213-2600(20)30316-7openalex-snapshot
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
inferredcites →https://doi.org/10.1038/d41586-020-02958-2openalex-snapshot
Latin America’s embrace of an unproven COVID treatment is hindering drug trials
inferredcites →https://doi.org/10.1038/s41586-020-2521-4openalex-snapshot
Factors associated with COVID-19-related death using OpenSAFELY
inferredcites →https://doi.org/10.1038/srep23138openalex-snapshot
Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
inferredcites →https://doi.org/10.1042/bj20120150openalex-snapshot
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
inferredcites →https://doi.org/10.1056/nejmoa2007764openalex-snapshot
Remdesivir for the Treatment of Covid-19 — Final Report
inferredcites →https://doi.org/10.1056/nejmoa2021436openalex-snapshot
Dexamethasone in Hospitalized Patients with Covid-19
inferredcites →https://doi.org/10.1111/j.1365-4632.2004.02253.xopenalex-snapshot
Ivermectin: pharmacology and application in dermatology
inferredcites →https://doi.org/10.1126/science.6308762openalex-snapshot
Ivermectin: A Potent New Antiparasitic Agent
inferredcites →https://doi.org/10.1136/bmj.l4898openalex-snapshot
RoB 2: a revised tool for assessing risk of bias in randomised trials
inferredcites →https://doi.org/10.1136/bmj.m1808openalex-snapshot
Interpreting a covid-19 test result
inferredcites →https://doi.org/10.1136/bmj.m3379openalex-snapshot
A living WHO guideline on drugs for covid-19 (2020-2023)
inferredcites →https://doi.org/10.1136/bmjopen-2015-010247openalex-snapshot
Plea for routinely presenting prediction intervals in meta-analysis
inferredcites →https://doi.org/10.1186/s13054-020-02902-wopenalex-snapshot
Clinical determinants for fatality of 44,672 patients with COVID-19
inferredcites →https://doi.org/10.1208/s12248-007-9000-9openalex-snapshot
The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review
inferredcites →https://doi.org/10.18433/jpps31457openalex-snapshot
Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis
inferredcites →https://doi.org/10.3389/fmed.2020.599533openalex-snapshot
COVID-19 Induced Acute Respiratory Distress Syndrome—A Multicenter Observational Study
inferredcites →https://doi.org/10.3389/fmicb.2015.00553openalex-snapshot
Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses
inferredcites →https://doi.org/10.3390/jcm9020580openalex-snapshot
Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.3897/pharmacia.73.e197010zenodo-depositor-declared
Strategies for drug repurposing in COVID-19
inferred← citeshttps://doi.org/10.1002/14651858.cd015017.pub2openalex-snapshot
Ivermectin for preventing and treating COVID-19
inferred← citeshttps://doi.org/10.1002/14651858.cd015017.pub3openalex-snapshot
Ivermectin for preventing and treating COVID-19
inferred← citeshttps://doi.org/10.1007/s13671-022-00368-3openalex-snapshot
Outpatient Management of COVID-19: A Primer for the Dermatologist
inferred← citeshttps://doi.org/10.1007/s40472-022-00368-zopenalex-snapshot
Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients
inferred← citeshttps://doi.org/10.1016/j.clinpr.2023.100248openalex-snapshot
Multiorgan failure from excessive polypharmacy self-medication with prescription and non-prescription drugs following SARS-CoV-2 infection: A case report
inferred← citeshttps://doi.org/10.1038/s41598-023-41760-8openalex-snapshot
A cross-lingual analysis on the spread of misinformation using the case of Ivermectin as a treatment for Covid-19
inferred← citeshttps://doi.org/10.1080/00325481.2026.2672183openalex-snapshot
Life-threatening neurotoxicity following off-label ivermectin use in metastatic breast cancer: a case report
inferred← citeshttps://doi.org/10.1080/01639625.2024.2334274openalex-snapshot
Prevalence of Legal, Prescription, and Illegal Drugs Aiming at Cognitive Enhancement across Sociodemographic Groups in Germany
inferred← citeshttps://doi.org/10.1080/02691728.2024.2400560openalex-snapshot
Mind the Guardrails: Epistemic Trespassing and Apt Deference
inferred← citeshttps://doi.org/10.1136/bmjgh-2022-010962openalex-snapshot
Quality of clinical evidence and political justifications of ivermectin mass distribution of COVID-19 kits in eight Latin American countries
inferred← citeshttps://doi.org/10.1155/2023/1879554openalex-snapshot
COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development
inferred← citeshttps://doi.org/10.1186/s12874-022-01646-1openalex-snapshot
Standard of care for COVID-19 in randomized clinical trials registered in trial registries and published in preprint servers and scholarly journals: a cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12879-022-07589-8openalex-snapshot
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
inferred← citeshttps://doi.org/10.12677/ojns.2023.112020openalex-snapshot
The Clinical Application of Ivermectin in COVID-19
inferred← citeshttps://doi.org/10.1515/bmc-2021-0017openalex-snapshot
SIT1 transporter as a potential novel target in treatment of COVID-19
inferred← citeshttps://doi.org/10.26633/rpsp.2024.36openalex-snapshot
Risk factors associated with severe COVID-19 outcomes in Jamaica: a cross-sectional study of national surveillance data
inferred← citeshttps://doi.org/10.3238/arztebl.m2021.0374openalex-snapshot
Recommendations on the in-hospital treatment of patients with COVID-19
inferred← citeshttps://doi.org/10.3238/arztebl.m2022.0203openalex-snapshot
Recommendations for the outpatient drug treatment of patients with COVID-19
inferred← citeshttps://doi.org/10.3389/fmed.2021.731436openalex-snapshot
Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review
inferred← citeshttps://doi.org/10.3389/fmed.2023.1139046openalex-snapshot
Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
inferred← citeshttps://doi.org/10.3389/fmicb.2022.843587openalex-snapshot
What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
inferred← citeshttps://doi.org/10.3389/fphar.2022.870493openalex-snapshot
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
inferred← citeshttps://doi.org/10.3389/fpubh.2022.788972openalex-snapshot
Ivermectin and the Integrity of Healthcare Evidence During COVID-19
inferred← citeshttps://doi.org/10.3389/frma.2026.1833223openalex-snapshot
Artificial intelligence to enhance research integrity in evidence-based medicine: toward scalable trustworthiness assessment
inferred← citeshttps://doi.org/10.3390/app12157800openalex-snapshot
Honey as an Adjuvant in the Treatment of COVID-19 Infection: A Review
inferred← citeshttps://doi.org/10.3390/ijms231911851openalex-snapshot
Systematic Down-Selection of Repurposed Drug Candidates for COVID-19
inferred← citeshttps://doi.org/10.3390/v15051138openalex-snapshot
Ivermectin Effect on In-Hospital Mortality and Need for Respiratory Support in COVID-19 Pneumonia: Propensity Score-Matched Retrospective Study
inferred← citeshttps://doi.org/10.53879/id.61.02.14233openalex-snapshot
PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY
inferred← citeshttps://doi.org/10.55489/njcm.130820222103openalex-snapshot
Few More Lessons Learnt from Covid-19: Health Technology Assessment (HTA) Perspective
inferred← citeshttps://doi.org/10.6084/m9.figshare.20364976openalex-snapshot
Additional file 7 of Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.